Aeterna Zentaris & Er-Kim Announce Partnership to Commercialize Macrilen in Eight European Countries
Istanbul, Turkey – January 31, 2022 – Er-Kim, a regional specialty pharmaceutical company, announced today the signature of an exclusive...
Aeterna Zentaris & Er-Kim Announce Partnership to Commercialize Macrilen in Eight European Countries
Er-Kim Announces Distribution Agreement and Acceptance of Application for BRUKINSA® in Turkey
Distribution agreement with Er-Kim for Bulgaria and Romania
Erkim Signs Agreement with Diurnal for the Distribution of ALKINDI® and CHRONOCORT® in Turkey
AnGes and Er-Kim enter into an agreement for the commercialization of Collategene® in Turkey